PL1988090T3 - Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie - Google Patents

Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie

Info

Publication number
PL1988090T3
PL1988090T3 PL06775249T PL06775249T PL1988090T3 PL 1988090 T3 PL1988090 T3 PL 1988090T3 PL 06775249 T PL06775249 T PL 06775249T PL 06775249 T PL06775249 T PL 06775249T PL 1988090 T3 PL1988090 T3 PL 1988090T3
Authority
PL
Poland
Prior art keywords
therrof
imidazol
carboxylic acid
acid derivatives
preparation methods
Prior art date
Application number
PL06775249T
Other languages
English (en)
Inventor
Jianhui Guo
Dong An
Original Assignee
Salubris Asset Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salubris Asset Man Co Ltd filed Critical Salubris Asset Man Co Ltd
Publication of PL1988090T3 publication Critical patent/PL1988090T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL06775249T 2006-02-20 2006-07-31 Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie PL1988090T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA2006100239910A CN101024643A (zh) 2006-02-20 2006-02-20 咪唑－5－羧酸类衍生物、制备方法及其应用
EP06775249.3A EP1988090B1 (en) 2006-02-20 2006-07-31 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
PCT/CN2006/001914 WO2007095789A1 (en) 2006-02-20 2006-07-31 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof

Publications (1)

Publication Number Publication Date
PL1988090T3 true PL1988090T3 (pl) 2013-10-31

Family

ID=38436915

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06775249T PL1988090T3 (pl) 2006-02-20 2006-07-31 Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie

Country Status (12)

Country Link
US (2) USRE44873E1 (pl)
EP (1) EP1988090B1 (pl)
JP (1) JP5250760B2 (pl)
KR (1) KR101179110B1 (pl)
CN (2) CN101024643A (pl)
AU (1) AU2006338796B2 (pl)
CA (1) CA2643005C (pl)
DK (1) DK1988090T3 (pl)
ES (1) ES2424154T3 (pl)
PL (1) PL1988090T3 (pl)
PT (1) PT1988090E (pl)
WO (1) WO2007095789A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
EP2103610B1 (en) * 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) * 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
JP2011523941A (ja) * 2008-05-15 2011-08-25 メルク・シャープ・エンド・ドーム・コーポレイション アンギオテンシンｉｉ受容体アンタゴニスト
CN101596189A (zh) * 2008-06-05 2009-12-09 上海艾力斯生物医药有限公司 含有咪唑-5-羧酸类衍生物的药用组合物
JP5575783B2 (ja) * 2008-12-12 2014-08-20 ファーマコステック カンパニー リミテッド トリフェニルメタン保護基の除去方法
KR101213467B1 (ko) * 2010-04-30 2012-12-20 진양제약주식회사 로자탄 대사체 이엑스피-3174 이수화물의 신규한 제조 방법
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
CN102558064B (zh) * 2012-01-29 2014-04-16 安润医药科技（苏州）有限公司 抗高血压化合物及其制备方法和应用，以及其在药学上可接受的盐
CN104610232B (zh) * 2013-11-01 2019-09-20 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
CN103965171A (zh) * 2014-04-30 2014-08-06 上海艾力斯医药科技有限公司 一种阿利沙坦酯的制备方法
CN106188012B (zh) * 2014-06-20 2018-11-30 深圳信立泰药业股份有限公司 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物
CN105218527B (zh) * 2015-10-10 2018-04-24 江苏宝众宝达药业有限公司 一种exp-3174的制备方法
WO2017125031A1 (zh) 2016-01-20 2017-07-27 深圳信立泰药业股份有限公司 血管紧张素ii受体拮抗剂代谢产物与nep抑制剂的复合物及其制备方法
CN119371408B (zh) * 2024-12-27 2025-04-22 安徽艾立德制药有限公司 一种无定形的阿利沙坦酯及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5616599A (en) 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
ES2155827T3 (es) * 1992-06-02 2001-06-01 Sankyo Co 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
JPH083162A (ja) * 1994-04-19 1996-01-09 Tanabe Seiyaku Co Ltd イミダゾピリジン誘導体及びその製法
CN1142793C (zh) * 1995-06-07 2004-03-24 G·D·瑟尔公司 环氧-甾族化合物醛甾酮拮抗剂和血管紧张肽ⅱ拮抗剂联合治疗用于治疗充血性心衰
DK1653950T3 (da) 2003-07-31 2008-05-26 Nicox Sa Nitrooxyderivater af Losartan, Valsatan, Candesartan, Telmisartan, Eprosartan og Olmesartan som angiotensin II-receptorblokkere til behandling af cardiovaskulære sygdomme
AU2004270161A1 (en) 2003-08-28 2005-03-17 Nicox S.A. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
JP5051897B2 (ja) 2005-04-22 2012-10-17 第一三共株式会社 骨代謝性疾患の予防又は治療のための医薬
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
EP2103610B1 (en) 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
CN101214242A (zh) 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物

Also Published As

Publication number Publication date
CA2643005C (en) 2012-05-15
JP5250760B2 (ja) 2013-07-31
KR20080096707A (ko) 2008-10-31
AU2006338796A1 (en) 2007-08-30
PT1988090E (pt) 2013-08-05
JP2009527509A (ja) 2009-07-30
ES2424154T3 (es) 2013-09-27
KR101179110B1 (ko) 2012-09-07
EP1988090B1 (en) 2013-05-01
CN101031562A (zh) 2007-09-05
US20090036505A1 (en) 2009-02-05
USRE44873E1 (en) 2014-04-29
EP1988090A1 (en) 2008-11-05
CN101024643A (zh) 2007-08-29
EP1988090A4 (en) 2010-06-30
CA2643005A1 (en) 2007-08-30
AU2006338796B2 (en) 2011-05-12
CN100506818C (zh) 2009-07-01
WO2007095789A1 (en) 2007-08-30
DK1988090T3 (da) 2013-08-05
US7858651B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
ZA201005202B (en) Azabicyclic carboxamide derivatives,preparation thereof and theapeutic use thereof
PL2046405T3 (pl) Biomateriały, ich wytwarzanie i zastosowanie
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
ZA201100210B (en) Pyridino-pyridinone derivatives,preparation thereof,and therapeutic use thereof
ZA200901268B (en) Substituted imidazolone derivatives, preparation and uses
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
EP2307344A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, PREPARATION AND USE THEREOF
IL201416A0 (en) Triazolopyridine carboxamide derivatives, preparation thereof and theraputic use thereof
IL204814A0 (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
EP2283005A4 (en) CISATRACURIUM DERIVATIVES, PREPARATION AND USES THEREOF
IL208771A0 (en) Iminopyridine derivatives and use thereof
IL192427A0 (en) Derivatives of sulindac, use thereof and preparation thereof
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
GB0719592D0 (en) Compound, use and method
GB0616111D0 (en) Agents, methods and uses
IL193384A0 (en) Substituted prolinamides, their preparation and their use as pharmaceuticals
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
SI2421864T1 (sl) 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL202474A0 (en) 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
GB0607562D0 (en) Method, composition and use